🇺🇸 C. difficile vaccine formulation 1. in United States

C. difficile vaccine formulation 1. (c-difficile-vaccine-formulation-1) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

C. difficile vaccine formulation 1. in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is C. difficile vaccine formulation 1. approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for C. difficile vaccine formulation 1. in United States?

Pfizer Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.